Skip to content

Single tooth implants in the posterior maxilla and mandible: a prospective study on clinical performance of Atlantis CustomBase solution with full-contour zirconia Atlantis Crowns.

Single tooth implants in the posterior maxilla and mandible: a prospective study on clinical performance of Atlantis CustomBase solution with full-contour zirconia Atlantis Crowns.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22032
Enrollment
50
Registered
2020-11-12
Start date
2020-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

One missing or failing tooth being a molar in the maxilla or mandible

Interventions

All patients are treated with an Astra Tech Implant EV. After a period of 3 months a screw-retained zirconia restoration is placed.

Sponsors

Dept. Oral and Maxillofacial Surgery, University Medical Center Groningen and Dentsply Sirona Implants, Mölndal, Sweden (dental implants and crowns)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients referred to our department for single-tooth implant therapy in the maxillary and mandibular posterior region are considered for inclusion. The following inclusion criteria are applied: - one missing or failing tooth being a molar in the maxilla or mandible; - enough bone to reach initial stability of the dental implant; - at least 18 year of age; - ASA score = 2 (Smeets et al. 1998); - adequate oral hygiene, i.e. Plaque Index Score (Silness and Lo?, 1964) and Gingival Index Score (Silness and Lo?, 1964) = 1; - mesial-distal width of diastema at least 8 mm; - patient is capable of understanding and giving informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: - presence of active clinical periodontal disease as expressed by probing pockets depths = 4 mm and bleeding on probing; - presence of peri-apical lesions or any other abnormalities in the posterior region as determined on a radiograph; - smoking; - a history of radiotherapy to the head and neck region; - use of intravenous bisphosphonates shorter than 10 years ago.

Design outcomes

Primary

MeasureTime frame
Peri-implant bone level change

Secondary

MeasureTime frame
Clinical items and patient satisfaction

Contacts

Public ContactHenny J.A. Meijer

University Medical Center Groningen

h.j.a.meijer@umcg.nl+31503613840

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)